Access cutting-edge gastric cancer treatment through this clinical trial at a research site in Scottsdale. Study-provided care at no cost to qualified participants.
Access gastric cancer specialists in Scottsdale at no cost
This study follows strict safety protocols and ethical guidelines
All study-related gastric cancer treatment provided free
This phase II trial studies the effect of the combination of ramucirumab and trifluridine/tipiracil or paclitaxel in treating patients with previously treated gastric or gastroesophageal junction cancer that has spread to other places in the body (advanced). Ramucirumab may damage tumor cells by targeting new blood vessel formation. Trifluridine/tipiracil is a chemotherapy pill and that may damage tumor cells by damaging their deoxyribonucleic acid (DNA). Paclitaxel may block cell growth by stop
Sponsor: Academic and Community Cancer Research United
Check if you qualify for this gastric cancer clinical trial in Scottsdale, AZ
If you're searching for gastric cancer treatment options in Scottsdale, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Scottsdale research site is actively enrolling participants for this clinical trial. You'll receive care from experienced gastric cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.